CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		58,504,000
Beginning balance at Dec. 31, 2021	$ 1,310,736	$ 5,850	$ 963,851	$ 358,598	$ (10,569)	$ (6,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	(45,452)			20,588		(66,040)
Stock based compensation expense	1,419		1,419
Common stock transactions related to stock based employee benefit plans (in shares)		7,000
Common stock transactions related to stock based employee benefit plans	106	$ 1	(5)		110
Common stock issued for stock options (in shares)		178,000
Common stock issued for stock options	3,403	$ 18	3,385
Issuance of common stock, pursuant to acquisitions (in shares)		2,550,000
Issuance of common stock, pursuant to acquisitions	90,234	$ 255	89,979
Conversion of options, pursuant to acquisition	3,833		3,833
Dividends on common stock	(7,994)			(7,994)
Increase (decrease) in shares during period (in shares)		2,735,000
Increase (decrease) in stockholders' equity during period	45,549	$ 274	98,611	12,594	110	(66,040)
Ending balance (in shares) at Mar. 31, 2022		61,239,000
Ending balance at Mar. 31, 2022	$ 1,356,285	$ 6,124	1,062,462	371,192	(10,459)	(73,034)
Beginning balance (in shares) at Dec. 31, 2022	71,617,852	71,618,000
Beginning balance at Dec. 31, 2022	$ 1,607,775	$ 7,162	1,377,802	423,863	(13,019)	(188,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income (loss)	30,427			11,827		18,600
Stock based compensation expense	2,642		2,642
Common stock transactions related to stock based employee benefit plans (in shares)		71,000
Common stock transactions related to stock based employee benefit plans	(165)	$ 8	(79)		(94)
Common stock issued for stock options (in shares)		128,000
Common stock issued for stock options	3,782	$ 12	3,770
Issuance of common stock, pursuant to acquisitions (in shares)		12,792,000
Issuance of common stock, pursuant to acquisitions	410,738	$ 1,279	409,459
Conversion of options, pursuant to acquisition	10,304		10,304
Dividends on common stock	(14,419)			(14,419)
Increase (decrease) in shares during period (in shares)		12,991,000
Increase (decrease) in stockholders' equity during period	$ 443,309	$ 1,299	426,096	(2,592)	(94)	18,600
Ending balance (in shares) at Mar. 31, 2023	84,609,320	84,609,000
Ending balance at Mar. 31, 2023	$ 2,051,084	$ 8,461	$ 1,803,898	$ 421,271	$ (13,113)	$ (169,433)